EP1087766A4 - Methode de traitement - Google Patents

Methode de traitement

Info

Publication number: EP1087766A4
Authority: EP; European Patent Office
Prior art keywords: treatment
Prior art date: 1998-06-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP99930327A

Other languages

German (de)

English (en)

Other versions

EP1087766A1 (fr

Inventor

Martin X Steiner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-16

Filing date

1999-06-16

Publication date

2001-11-21

1999-06-16 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2001-04-04 Publication of EP1087766A1 publication Critical patent/EP1087766A1/fr

2001-11-21 Publication of EP1087766A4 publication Critical patent/EP1087766A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Addiction (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP99930327A 1998-06-16 1999-06-16 Methode de traitement Withdrawn EP1087766A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9812941.4A GB9812941D0 (en)	1998-06-16	1998-06-16	Method of treatment
GB9812941		1998-06-16
PCT/US1999/013623 WO1999065491A1 (fr)	1998-06-16	1999-06-16	Methode de traitement

Publications (2)

Publication Number	Publication Date
EP1087766A1 EP1087766A1 (fr)	2001-04-04
EP1087766A4 true EP1087766A4 (fr)	2001-11-21

Family

ID=10833832

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP99930327A Withdrawn EP1087766A4 (fr)	1998-06-16	1999-06-16	Methode de traitement

Country Status (20)

Country	Link
EP (1)	EP1087766A4 (fr)
JP (1)	JP2002518330A (fr)
KR (1)	KR20010052895A (fr)
CN (1)	CN1305379A (fr)
AP (1)	AP2000002002A0 (fr)
AU (1)	AU740749B2 (fr)
BG (1)	BG105127A (fr)
BR (1)	BR9911150A (fr)
CA (1)	CA2335236A1 (fr)
CZ (1)	CZ20004698A3 (fr)
EA (1)	EA003584B1 (fr)
GB (1)	GB9812941D0 (fr)
HU (1)	HUP0102507A3 (fr)
IL (1)	IL139943A0 (fr)
NO (1)	NO20006383L (fr)
NZ (1)	NZ508532A (fr)
PL (1)	PL345261A1 (fr)
SK (1)	SK19192000A3 (fr)
WO (1)	WO1999065491A1 (fr)
ZA (1)	ZA200007396B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0303827A2 (hu) *	2000-08-28	2004-04-28	Synthon B.V.	Paroxetinkészítmények és eljárások ezek előállítására
EP1465601A4 (fr)	2001-12-28	2006-02-15	Teva Pharma	Formulation pharmaceutique stable d'hydrochlorure de paroxetine anhydre et procede de preparation
EP1791531A1 (fr) *	2004-08-20	2007-06-06	Alpharma, Inc.	Formulations à base de paroxétine
FR2926221A1 (fr) *	2008-01-14	2009-07-17	Tassin Thomas	Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996024595A1 (fr) *	1995-02-06	1996-08-15	Smithkline Beecham Plc	Nouvelles formes de l'hydrochlorure de paroxetine
WO1997034602A1 (fr) *	1996-03-20	1997-09-25	Smithkline Beecham Plc	Therapie des etats depressifs par la paroxetine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2058061T3 (es) *	1985-10-25	1994-11-01	Beecham Group Plc	Derivado de piperidina, su preparacion y su uso como medicamento.
US5371092A (en) *	1990-11-24	1994-12-06	Beecham Group, P.L.C.	Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia

1998
- 1998-06-16 GB GBGB9812941.4A patent/GB9812941D0/en not_active Ceased
1999
- 1999-06-16 EA EA200100041A patent/EA003584B1/ru not_active IP Right Cessation
- 1999-06-16 AU AU46885/99A patent/AU740749B2/en not_active Ceased
- 1999-06-16 EP EP99930327A patent/EP1087766A4/fr not_active Withdrawn
- 1999-06-16 JP JP2000554371A patent/JP2002518330A/ja not_active Withdrawn
- 1999-06-16 HU HU0102507A patent/HUP0102507A3/hu unknown
- 1999-06-16 IL IL13994399A patent/IL139943A0/xx unknown
- 1999-06-16 CZ CZ20004698A patent/CZ20004698A3/cs unknown
- 1999-06-16 PL PL99345261A patent/PL345261A1/xx not_active Application Discontinuation
- 1999-06-16 CA CA002335236A patent/CA2335236A1/fr not_active Abandoned
- 1999-06-16 WO PCT/US1999/013623 patent/WO1999065491A1/fr not_active Ceased
- 1999-06-16 KR KR1020007014240A patent/KR20010052895A/ko not_active Withdrawn
- 1999-06-16 AP APAP/P/2000/002002A patent/AP2000002002A0/en unknown
- 1999-06-16 BR BR9911150-0A patent/BR9911150A/pt not_active Application Discontinuation
- 1999-06-16 CN CN99807465A patent/CN1305379A/zh active Pending
- 1999-06-16 SK SK1919-2000A patent/SK19192000A3/sk unknown
- 1999-06-16 NZ NZ508532A patent/NZ508532A/en unknown
2000
- 2000-12-12 ZA ZA200007396A patent/ZA200007396B/xx unknown
- 2000-12-14 NO NO20006383A patent/NO20006383L/no unknown
2001
- 2001-01-08 BG BG105127A patent/BG105127A/xx unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996024595A1 (fr) *	1995-02-06	1996-08-15	Smithkline Beecham Plc	Nouvelles formes de l'hydrochlorure de paroxetine
WO1997034602A1 (fr) *	1996-03-20	1997-09-25	Smithkline Beecham Plc	Therapie des etats depressifs par la paroxetine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; LEVIN EDWARD D_(A): "Sertraline attenuates hyperphagia in rats following nicotine withdrawal.", XP002173579, retrieved from DIALOG *
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, vol. 44, pages 51 - 61 *
See also references of WO9965491A1 *

Also Published As

Publication number	Publication date
EP1087766A1 (fr)	2001-04-04
WO1999065491A1 (fr)	1999-12-23
NO20006383D0 (no)	2000-12-14
EA200100041A1 (ru)	2001-06-25
KR20010052895A (ko)	2001-06-25
GB9812941D0 (en)	1998-08-12
HUP0102507A2 (hu)	2002-05-29
CN1305379A (zh)	2001-07-25
AP2000002002A0 (en)	2000-12-31
ZA200007396B (en)	2002-02-27
BG105127A (en)	2001-11-30
AU740749B2 (en)	2001-11-15
CZ20004698A3 (cs)	2002-02-13
IL139943A0 (en)	2002-02-10
NZ508532A (en)	2003-08-29
BR9911150A (pt)	2001-03-06
NO20006383L (no)	2000-12-14
PL345261A1 (en)	2001-12-03
HUP0102507A3 (en)	2003-12-29
CA2335236A1 (fr)	1999-12-23
EA003584B1 (ru)	2003-06-26
AU4688599A (en)	2000-01-05
JP2002518330A (ja)	2002-06-25
SK19192000A3 (sk)	2001-05-10

Publication	Publication Date	Title
GB9824436D0 (en)	1999-01-06	Methods of treatment
HU0001471D0 (en)	2000-06-28	New method of treatment
GB9715295D0 (en)	1997-09-24	Novel method of treatment
GB9712866D0 (en)	1997-08-20	Novel method of treatment
GB9707693D0 (en)	1997-06-04	Novel method of treatment
GB9715298D0 (en)	1997-09-24	Novel method of treatment
GB9715306D0 (en)	1997-09-24	Novel method of treatment
PL341667A1 (en)	2001-04-23	Method of treating cooped
PL345261A1 (en)	2001-12-03	Method of treatment
PL349421A1 (en)	2002-07-29	Novel method of treatment
GB9822681D0 (en)	1998-12-09	Method of treatment
GB9811961D0 (en)	1998-07-29	Method of treatment
GB9822459D0 (en)	1998-12-09	Method of treatment
GB9808479D0 (en)	1998-06-17	Method of treatment
GB9818776D0 (en)	1998-10-21	Method of treatment
EG24158A (en)	2008-08-20	Novel method of treatment
GB9824789D0 (en)	1999-01-06	Novel method of treatment
GB9824790D0 (en)	1999-01-06	Novel method of treatment
GB9824871D0 (en)	1999-01-06	Novel method of treatment
SI1135128T1 (sl)	2007-12-31	Nov postopek zdravljenja
GB9824208D0 (en)	1998-12-30	Methods of treatment
GB9800707D0 (en)	1998-03-11	Methods of treatment
GB9822458D0 (en)	1998-12-09	Methods of treatment
ZA987316B (en)	1999-03-15	Method of treatment
GB9724289D0 (en)	1998-01-14	Method of treatment

Legal Events

Date	Code	Title	Description
2001-02-16	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-04-04	17P	Request for examination filed	Effective date: 20001128
2001-04-04	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-04-04	AX	Request for extension of the european patent	Free format text: RO PAYMENT 20001128;SI PAYMENT 20001128
2001-09-26	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/445 A, 7A 61K 9/20 B
2001-11-21	A4	Supplementary search report drawn up and despatched	Effective date: 20011008
2001-11-21	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2004-03-31	17Q	First examination report despatched	Effective date: 20040217
2004-11-12	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-12-29	18D	Application deemed to be withdrawn	Effective date: 20040629
2008-01-25	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1035669 Country of ref document: HK